Crestor Tablet, Film Coated
Product Images NDC 0310-7560

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 0310-7560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural_formula (Structural Formula)

Chemical structure of Rosuvastatin calcium, the active ingredient in Crestor tablets. The diagram shows the molecular arrangement including the fluorophenyl group, sulfonyl methyl group, hydroxyl groups, and the calcium ion complex.*

FDA Label Image

Figure_1_time_jupiter (Figure 1 Time Jupiter)

A Kaplan-Meier cumulative incidence curve over approximately 5 years comparing Rosuvastatin (Rosuva) and placebo groups. The y-axis shows cumulative incidence percentage, and the x-axis represents years. The graph includes hazard ratio (HR 0.56), 95% confidence interval (0.46-0.69), and a p-value (<0.001). Numbers at risk for both RSV and placebo are shown below the graph at various time points.*

FDA Label Image

Figure_2-major_jupiter (Figure 2 Major Jupiter)

A table presenting clinical event outcomes comparing Crestor (Rosuvastatin) 20 mg with placebo 20 mg, including number of events, hazard ratios, confidence intervals, and P values for endpoints such as primary major cardiovascular events (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization. The table also includes a hazard ratio plot demonstrating relative risk reduction.*

FDA Label Image

Figure_3_percent_dyslipidemia (Figure 3 Percent Dyslipidemia)

Box plot graph depicting percent change from baseline in LDL-C levels for four statin drugs: Crestor (rosuvastatin), Atorvastatin, Simvastatin, and Pravastatin. The x-axis lists doses in mg, ranging from 10 to 80 mg depending on the drug, while the y-axis shows percent change from 0 to -75%. The graph compares LDL-C reduction across different dosages of each statin.*

FDA Label Image

Crestor_5mg (Crestor 5mg)

Label for Crestor 5 mg tablets, film-coated oral tablets containing rosuvastatin, with a package count of 90 tablets. Manufactured for AstraZeneca Pharmaceuticals LP and made by IPR Pharmaceuticals, Inc. in Switzerland. The label includes dosage strength, NDC code 0310-7560-90, and storage and safety warnings. AstraZeneca branding is visible on the label.*

FDA Label Image

Crestor_10mg (Crestor 10mg)

Label for Crestor 10 mg tablets, containing rosuvastatin as the active ingredient. The label shows a package size of 90 tablets, manufactured for AstraZeneca Pharmaceuticals LP. The product is labeled Rx only, with manufacturing details including IPR Pharmaceuticals, Inc. in Canóvanas, Puerto Rico, and a product origin of Switzerland. The AstraZeneca logo appears prominently at the bottom.*

FDA Label Image

Crestor_20mg (Crestor 20mg)

Crestor 20 mg tablets, film-coated oral tablets containing rosuvastatin. The label shows a package of 90 tablets manufactured for AstraZeneca Pharmaceuticals LP, Wilmington, DE, by IPR Pharmaceuticals, Inc. The product is labeled as Rx only and is a product of Switzerland. Label includes dosage strength, NDC 0310-7580-90, storage instructions, and the AstraZeneca logo.*

FDA Label Image

Crestor_20mg (Crestor 40mg)

Label for Crestor rosuvastatin 40 mg tablets, oral film-coated tablets. The package contains 30 tablets. Manufactured for AstraZeneca Pharmaceuticals LP, Wilmington, DE, by IPR Pharmaceuticals, Inc. The label includes NDC 0310-7590-30 and storage instructions, with the AstraZeneca logo at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.